Literature DB >> 24174875

Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica.

Ying Wang1, Qinfu Zhao, Yanchen Hu, Lizhang Sun, Ling Bai, Tongying Jiang, Siling Wang.   

Abstract

The goal of the present study was to compare the drug release properties and stability of the nanoporous silica with different pore architectures as a matrix for improved delivery of poorly soluble drugs. For this purpose, three dimensional ordered macroporous (3DOM) silica with 3D continuous and interconnected macropores of different sizes (200 nm and 500 nm) and classic mesoporous silica (ie, Mobil Composition of Matter [MCM]-41 and Santa Barbara Amorphous [SBA]-15) with well-ordered two dimensional (2D) cylindrical mesopores were successfully fabricated and then loaded with the model drug indomethacin (IMC) via the solvent deposition method. Scanning electron microscopy (SEM), N2 adsorption, differential scanning calorimetry (DSC), and X-ray diffraction (XRD) were applied to systematically characterize all IMC-loaded nanoporous silica formulations, evidencing the successful inclusion of IMC into nanopores, the reduced crystallinity, and finally accelerated dissolution of IMC. It was worth mentioning that, in comparison to 2D mesoporous silica, 3DOM silica displayed a more rapid release profile, which may be ascribed to the 3D interconnected pore networks and the highly accessible surface areas. The results obtained from the stability test indicated that the amorphous state of IMC entrapped in the 2D mesoporous silica (SBA-15 and MCM-41) has a better physical stability than in that of 3DOM silica. Moreover, the dissolution rate and stability of IMC loaded in 3DOM silica was closely related to the pore size of macroporous silica. The colorimetric 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Cell Counting Kit (CCK)-8 assays in combination with direct morphology observations demonstrated the good biocompatibility of nanoporous silica, especially for 3DOM silica and SBA-15. The present work encourages further study of the drug release properties and stability of drug entrapped in different pore architecture of silica in order to realize their potential in oral drug delivery.

Entities:  

Keywords:  3D ordered macroporous silica; in vitro cytotoxicity; in vitro dissolution; mesoporous silica; poorly soluble drugs; stability test

Mesh:

Substances:

Year:  2013        PMID: 24174875      PMCID: PMC3808157          DOI: 10.2147/IJN.S52605

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  42 in total

1.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Dissolution rate enhancement by adsorption of poorly soluble drugs on hydrophilic silica aerogels.

Authors:  Irina Smirnova; Supakij Suttiruengwong; Matthias Seiler; Wolfgang Arlt
Journal:  Pharm Dev Technol       Date:  2004-11       Impact factor: 3.133

Review 3.  Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

Authors:  N Blagden; M de Matas; P T Gavan; P York
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

Review 4.  Oral lipid-based formulations.

Authors:  David J Hauss
Journal:  Adv Drug Deliv Rev       Date:  2007-05-26       Impact factor: 15.470

Review 5.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.

Authors:  Igor I Slowing; Juan L Vivero-Escoto; Chia-Wen Wu; Victor S-Y Lin
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

6.  Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells.

Authors:  Teemu Heikkilä; Hélder A Santos; Narendra Kumar; Dmitry Yu Murzin; Jarno Salonen; Timo Laaksonen; Leena Peltonen; Jouni Hirvonen; Vesa-Pekka Lehto
Journal:  Eur J Pharm Biopharm       Date:  2009-12-16       Impact factor: 5.571

7.  Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores

Authors: 
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

8.  Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica.

Authors:  Randy Mellaerts; Raf Mols; Jasper A G Jammaer; Caroline A Aerts; Pieter Annaert; Jan Van Humbeeck; Guy Van den Mooter; Patrick Augustijns; Johan A Martens
Journal:  Eur J Pharm Biopharm       Date:  2007-11-23       Impact factor: 5.571

9.  Cytotoxicity of mesoporous silica nanomaterials.

Authors:  Anthony J Di Pasqua; Krishna K Sharma; Yan-Li Shi; Bonnie B Toms; Wayne Ouellette; James C Dabrowiak; Tewodros Asefa
Journal:  J Inorg Biochem       Date:  2008-01-09       Impact factor: 4.155

10.  In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.

Authors:  Bao Chen; Zhouhua Wang; Guilan Quan; Xinsheng Peng; Xin Pan; Rongchang Wang; Yuehong Xu; Ge Li; Chuanbin Wu
Journal:  Int J Nanomedicine       Date:  2012-01-06
View more
  8 in total

Review 1.  Advances in the design of macroporous polymer scaffolds for potential applications in dentistry.

Authors:  Sidi A Bencherif; Thomas M Braschler; Philippe Renaud
Journal:  J Periodontal Implant Sci       Date:  2013-12-31       Impact factor: 2.614

Review 2.  Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Fatemeh Mehdizadeh; Hedieh Malekzad; Alireza Ghasemi; Sajad Bahrami; Hossein Zare; Mohsen Moghoofei; Amin Hekmatmanesh; Michael R Hamblin
Journal:  Nanoscale       Date:  2017-01-26       Impact factor: 7.790

3.  Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction.

Authors:  Han Li; Jing Zhu; Yan-Wu Xu; Fang-Fang Mou; Xiao-Li Shan; Qiang-Li Wang; Bao-Nian Liu; Ke Ning; Jia-Jia Liu; Ya-Chao Wang; Jin-Xia Mi; Xiaohui Wei; Shui-Jin Shao; Guo-Hong Cui; Rong Lu; Hai-Dong Guo
Journal:  Redox Biol       Date:  2022-06-24       Impact factor: 10.787

4.  A Comparative Study of the Use of Mesoporous Carbon and Mesoporous Silica as Drug Carriers for Oral Delivery of the Water-Insoluble Drug Carvedilol.

Authors:  Cuiyan Han; Haitao Huang; Yan Dong; Xiaoyu Sui; Baiyu Jian; Wenquan Zhu
Journal:  Molecules       Date:  2019-05-07       Impact factor: 4.411

Review 5.  Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy.

Authors:  Albert Yu; Xiaoyong Dai; Zixian Wang; Huaqing Chen; Bing Guo; Laiqiang Huang
Journal:  Biosensors (Basel)       Date:  2022-02-10

Review 6.  Interactions between Nanoparticles and Intestine.

Authors:  Manuela Vitulo; Elisa Gnodi; Raffaella Meneveri; Donatella Barisani
Journal:  Int J Mol Sci       Date:  2022-04-14       Impact factor: 6.208

7.  In-Vitro and In-Vivo Evaluation of Velpatasvir- Loaded Mesoporous Silica Scaffolds. A Prospective Carrier for Drug Bioavailability Enhancement.

Authors:  Yasir Mehmood; Ikram Ullah Khan; Yasser Shahzad; Rizwan Ullah Khan; Muhammad Shahid Iqbal; Haseeb Ahmad Khan; Ikrima Khalid; Abid Mehmood Yousaf; Syed Haroon Khalid; Sajid Asghar; Muhammad Asif; Talib Hussain; Shefaat Ullah Shah
Journal:  Pharmaceutics       Date:  2020-03-28       Impact factor: 6.321

8.  Hybrid Porous Microparticles Based on a Single Organosilica Cyclophosphazene Precursor.

Authors:  Vanessa Poscher; George S Pappas; Oliver Brüggemann; Ian Teasdale; Yolanda Salinas
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.